New weapon tested against rare, Hard-to-Treat cancers

NCT ID NCT07129252

Recruiting now Disease control Sponsor: Crinetics Pharmaceuticals Inc. Source: ClinicalTrials.gov ↗

Summary

This early-stage clinical trial is testing a new drug called CRN09682 for people with advanced neuroendocrine tumors and other solid tumors that have a specific marker (SST2). The main goals are to find a safe and tolerable dose and to see if the drug shows early signs of helping to control the cancer. The study will enroll about 150 participants whose cancer has progressed despite other treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Crinetics Study Site
RECRUITING

Duarte, California, 91010, United States
Crinetics Study Site
RECRUITING

Newport Beach, California, 92663, United States
Crinetics Study Site
RECRUITING

Orange, California, 92868, United States
Crinetics Study Site
RECRUITING

San Francisco, California, 60637, United States
Crinetics Study Site
RECRUITING

Denver, Colorado, 80218, United States
Crinetics Study Site
RECRUITING

New Haven, Connecticut, 48201, United States
Crinetics Study Site
RECRUITING

Atlanta, Georgia, 30322, United States
Crinetics Study Site
RECRUITING

Lexington, Kentucky, 40536, United States
Crinetics Study Site
RECRUITING

Metairie, Louisiana, 70006, United States
Crinetics Study Site
RECRUITING

Grand Rapids, Michigan, 49503, United States
Crinetics Study Site
RECRUITING

Philadelphia, Pennsylvania, 19111, United States
Crinetics Study Site
RECRUITING

Austin, Texas, 78758, United States
Crinetics Study Site
RECRUITING

Houston, Texas, 70030, United States
Crinetics Study Site
RECRUITING

Irving, Texas, 75039, United States
Crinetics Study Site
RECRUITING

Salt Lake City, Utah, 84112, United States
Crinetics Study Site
RECRUITING

Charlottesville, Virginia, 22908, United States
Crinetics Study Site
RECRUITING

Fairfax, Virginia, 22031, United States
Crinetics Study Site
RECRUITING

Barcelona, 08023, Spain
Crinetics Study Site
RECRUITING

Barcelona, 08035, Spain
Crinetics Study Site
RECRUITING

Madrid, 28040, Spain
Crinetics Study Site
RECRUITING

Madrid, 28041, Spain

Conditions

Explore the condition pages connected to this study.

NEUROENDOCRINE NEOPLASM NEUROENDOCRINE TUMORS SST2-POSITIVE NEUROENDOCRINE NEOPLASMS